Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer

2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer

US Patent 10376510 · Granted Aug 13, 2019

Estimated economic value: $29,394,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of plasma kallikrein and uses thereof2025
Therapeutically active compounds and their methods of use2025
Therapeutically active compounds and their methods of use2025
Therapeutically active compounds and their methods of use2025
Plasma kallikrein inhibitors and uses thereof2025
Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer2024
Heteroaryl plasma kallikrein inhibitors2024
Inhibitors of cellular metabolic processes2024
Inhibitors of cellular metabolic processes2024
Compounds and methods useful for stabilizing phenylalanine hydroxylase mutations2024
Inhibitors of plasma kallikrein and uses thereof2024
Therapeutically active compounds and their methods of use2023